Alpha Teknova (TKNO) Cash from Financing Activities (2020 - 2026)
Alpha Teknova (TKNO) reported Cash from Financing Activities of -$88000.0 for Q1 2026, down 69.23% year-over-year from -$286000.0 in Q1 2025, and down 137.84% quarter-over-quarter from -$37000.0 in Q4 2025.
Alpha Teknova (TKNO) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Cash from Financing Activities data on file, last reported at -$88000.0 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$88000.0, down 69.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $115000.0 (down 99.24% YoY), and the FY2025 annual result was $151000.0, down 98.99% from the prior year.
- Cash from Financing Activities declined to -$88000.0 in Q1 2026 per TKNO's latest filing, from -$37000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $15.4 million in Q3 2024 and troughed at -$621000.0 in Q4 2023.
- A 5-year average of $2.2 million and a median of -$28000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 514100.0% in 2022, then tumbled 1272.0% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $5.1 million in 2022, then tumbled by 112.08% to -$621000.0 in 2023, then surged by 85.99% to -$87000.0 in 2024, then soared by 57.47% to -$37000.0 in 2025, then slumped by 137.84% to -$88000.0 in 2026.
- Business Quant data shows TKNO's Cash from Financing Activities at -$88000.0 in Q1 2026, -$37000.0 in Q4 2025, and $268000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Alpha Teknova | 239.62 Mn | 221.84 Mn | 3.78 Mn | -88,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88,000.00 |
| Mar 31, 2026 | -88,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | 268,000.00 |
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 15.37 Mn |
| Sep 30, 2024 | 15.37 Mn |
| Jun 30, 2024 | -47,000.00 |
| Jun 30, 2024 | -47,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Dec 31, 2023 | -621,000.00 |
| Dec 31, 2023 | -621,000.00 |